"10.1371_journal.pone.0102136","plos one","2014-08-25T00:00:00Z","Danielle A Simmons; Juliet K Knowles; Nadia P Belichenko; Gargi Banerjee; Carly Finkle; Stephen M Massa; Frank M Longo","Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America; Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Neurology and Laboratory for Computational Neurochemistry and Drug Discovery, San Francisco Veterans Affairs Medical Center, and Department of Neurology, University of California San Francisco, San Francisco, California, United States of America","Conceived and designed the experiments: DAS JKK FML. Performed the experiments: DAS JKK NPB GB CF. Analyzed the data: DAS. Wrote the paper: DAS SMM FML.","Drs. Longo and Massa are named inventors on the following patents regarding the compound in this report: Pharmaceutical formulations comprising neurotrophin mimetics (20100267727); Neurotrophin mimetics and uses thereof (20110230479); crystalline forms of neurotrophin mimetic compounds and their salts (20130005731); and, neurotrophin mimetics and uses thereof (20140100224). Dr. Longo has financial interests in PharmatrophiX, a company focused on the development of neurotrophin receptor ligands. The changes to this statement do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","08","Danielle A Simmons","DAS",7,TRUE,3,5,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
